Genetron Holdings Profit Margin

Genetron Holdings (GTH) currently reports a profit margin of -123.24% as of December 2022. That compares with -93.72% in the prior-year period — down 31.5% year over year. That is below the Healthcare sector average of 13.76%. Use the charts on this page to explore Genetron Holdings's profit margin history and peer comparisons.

Genetron Holdings's profit margin decreased from -93.72% to -123.24% — a 31.5% year-over-year decrease (period ending December 2022). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Genetron Holdings's profit margin of -123.24% is lower than the Healthcare sector average of 13.76%. That is roughly 995.7% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' profit margin, but Genetron Holdings's current -123.24% should be judged against Healthcare norms (sector average: 13.76%) and against GTH's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current profit margin of -123.24%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 13.76%. From there, open related valuation or income-statement pages for Genetron Holdings, and consider following GTH for alerts when major investors trade the stock.